TBC Grifols Australia Pty Ltd
Product name
TBC
Sponsor
Accepted date
Oct-2023
Active ingredients
Fibrinogen, human thrombin
Proposed indication
As supportive treatment in children where standard surgical techniques are insufficient, for improvement of hemostasis.
Application type
C (new indication)
Publication date
Oct-2023